Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations
Fatemeh Atyabi
International Journal of Nanomedicine, 2011
View PDFchevron_right
Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations
Fatemeh Atyabi
2011
View PDFchevron_right
Nanoparticle-Mediated Drug Delivery of Doxorubicin Induces a Differentiated Clonogenic Inactivation in 3D Tumor Spheroids In Vitro
Iulia Savu
International Journal of Molecular Sciences
View PDFchevron_right
Enhanced tumor uptake and activity of nanoplex-loaded doxorubicin
James Mixson
Biochemical and Biophysical Research Communications, 2019
View PDFchevron_right
Lipid-functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot Study
Arun Iyer
Clinical Orthopaedics and Related Research®, 2013
View PDFchevron_right
SCKs as nanoparticle carriers of doxorubicin: investigation of core composition on the loading, release and cytotoxicity profiles
Sheila Stewart, Karen Wooley
Chemical Communications, 2008
View PDFchevron_right
Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors
Alexander Eggermont
The FASEB Journal, 2011
View PDFchevron_right
Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody
Mohammad Javad Rasaee
Artificial Cells, Nanomedicine, and Biotechnology, 2017
View PDFchevron_right
Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery
민직 김
Advanced healthcare materials, 2014
View PDFchevron_right
Doxorubicin layer-by-layer nanoparticles for controlled delivery and effective treatment of pancreatic cancer
poonam gangwar
Journal of Drug Delivery and Therapeutics
View PDFchevron_right
Advances in nano delivery systems for doxorubicin an updated insight.pdf
Muhammad Ovais
View PDFchevron_right
Bio-Responsive Carriers for Controlled Delivery of Doxorubicin to Cancer Cells
Marieta Constantin
Pharmaceutics
View PDFchevron_right
Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative
Chiara Dianzani
Nanomaterials, 2018
View PDFchevron_right
Enhancing Tumor Penetration of Nanomedicines
Fabian Kiessling
Biomacromolecules, 2017
View PDFchevron_right
Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier
susmita mitra
Journal of Controlled Release, 2001
View PDFchevron_right
Galactoxyloglucan-Modified Nanocarriers of Doxorubicin for Improved Tumor-Targeted Drug Delivery with Minimal Toxicity
Mini Saraswathy, Manu Joseph, Sreelekha Tt
Journal of Biomedical Nanotechnology, 2014
View PDFchevron_right
Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy
Lucas Ferreira
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016
View PDFchevron_right
A Novel Approach On Drug Delivery: Investigation Of A New Nano-Formulation Of Liposomal Doxorubicin And Biological Evaluation Of Entrapped Doxorubicin On Various Osteosarcoma Cell Lines
Cell Journal Yakhteh
Volume 19, Supplement 1, Spring 2017, 2017
View PDFchevron_right
Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models
Samuel Vidal Mussi
International journal of pharmaceutics, 2016
View PDFchevron_right
New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles
Samuel Mussi
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013
View PDFchevron_right
A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System
HL Wong
Journal of Pharmacology and Experimental Therapeutics, 2006
View PDFchevron_right
Novel Nanostructured Lipid Carrier Co-Loaded with Doxorubicin and Docosahexaenoic Acid Demonstrates Enhanced in Vitro Activity and Overcomes Drug Resistance in MCF-7/Adr Cells
Samuel Mussi
Pharmaceutical research, 2014
View PDFchevron_right
Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice
J. Talmadge
International journal of pharmaceutics, 2005
View PDFchevron_right
Conventional Nanosized Drug Delivery Systems for Cancer Applications
Luisa Di Marzio
Advances in Experimental Medicine and Biology
View PDFchevron_right
Biocompatible nanogel derived from functionalized dextrin for targeted delivery of doxorubicin hydrochloride to MG 63 cancer cells
Paulomi Ghosh
Carbohydrate Polymers, 2017
View PDFchevron_right
Advances in nano-delivery systems for doxorubicin: an updated insight
Abida Raza
2018
View PDFchevron_right
Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery
Young-Il Jeong
International Journal of Nanomedicine, 2015
View PDFchevron_right
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
Arun Iyer
BMC Cancer, 2009
View PDFchevron_right
Drug-Loaded Nanocarriers: Passive Targeting and Crossing of Biological Barriers
harjot ghuman
View PDFchevron_right
Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice
DaiHai Nguyen
View PDFchevron_right
Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells
Gayle Woloschak
Cancer Research, 2011
View PDFchevron_right